425: Strive, Semler Scientific Merger Communication

Strive Inc. reposts communication regarding its proposed business combination with Semler Scientific Inc. on X.com.

Summary

• Strive, Inc. filed a Form 425 communication concerning its proposed business combination with Semler Scientific, Inc.
• The communication was reposted on X.com by Pierre Rochard, a Board Member of Strive, Inc., on September 30, 2025.
• The filing primarily serves as a cautionary statement regarding forward-looking statements related to the merger, outlining inherent risks and uncertainties.
• It advises investors and stockholders to read the Registration Statement on Form S-4, including the Information Statement/Proxy Statement/Prospectus, when they become available for important information.
• Details on where to find additional SEC filings and information about Strive and Semler Scientific are provided.

Sentiment

Score: 5

Explanation: The filing is a procedural communication primarily focused on outlining forward-looking statements and extensive risks associated with a proposed merger. It does not present current financial results or operational updates, leading to a neutral sentiment with a strong emphasis on potential challenges.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors, including unknown or unpredictable factors, could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

Forward-looking statements include expectations regarding the proposed transaction's strategic and financial benefits, its impact on the combined company's future financial performance, the timing of closing, and the ability to successfully integrate the combined businesses. These statements are subject to significant risks and uncertainties.

Management Comments

• Pierre Rochard, Board Member of Strive, Inc., reposted the communication on X.com on September 30, 2025.

Industry Context

The filing highlights the strategic consideration of Bitcoin treasury strategies and the associated risks with Bitcoin and other digital assets, indicating a potential shift or emphasis on digital asset integration within the combined entity's operations, aligning with broader trends in corporate digital asset adoption.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is listed as a risk factor for the proposed transaction.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is available in its definitive proxy statement filed on July 17, 2025, for its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock in connection with the proposed transaction.
• Customers of both Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Business and employee relationships could change as a result of the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock.
• The Form S-4 will include an Information Statement/Proxy Statement/Prospectus for Strive and Semler Scientific.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek approval of the proposed transaction.
• Successful integration of the combined businesses post-merger.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Digital Assets, Corporate Governance